Risk assessment for hereditary breast cancer: BRCA1 and BRCA2

Kendra-Ann I. Seenandan-Sookdeo, Jo-Ann V. Sawatzky

Abstract


The recent explosion of hereditary breast cancer genetic research has strengthened our understanding of genetic influences on health and disease. These scientific advances have significant implications for clinical oncology nurses and advanced practice nurses. In this paper, the Human Response to Illness Model (Mitchell, Gallucci, & Fought, 1991) is utilized to gain a comprehensive understanding of breast cancer related to the human response of genetic mutations. Accordingly, the research literature related to the physiological, pathophysiological, behavioural, and experiential perspectives of BRCA-related breast cancer will be highlighted. This research-based evidence will provide oncology nurses with the skills to establish a holistic plan of care for women with an actual or potential genetic risk for breast cancer.


Full Text:

PDF

References


Barse, P.M. (2006). How to Perform a Genetic Assessment. In A.S.

Tranin, A. Masny & J. Jenkins (Eds.), Genetics in Oncology Practice:

Cancer Risk Assessment (2nd ed., pp. 57–73). Pittsburgh, PA:

Oncology Nursing Association.

Berliner, J.L., & Fay, A.M. (2007). Risk assessment and genetic

counseling for hereditary breast and ovarian cancer:

Recommendations of the National Society of Genetic Counselors.

The American Journal of Human Genetics, 16, 241–260.

Brown, K.L., Moglia, D.M., & Grumet, S. (2007). Genetic counseling for

breast cancer risk: General concepts, challenging themes and

future directions. Breast Disease, 27, 69–96.

Canadian Cancer Society/National Cancer Institute of Canada.

(2009). Canadian Cancer Statistics, ISSN 0835-2976.

Carroll, J.C., Cremin, C., Allanson, J., Blaine, S.M., Dorman, H.,

Gibbons, C.A., et al. (2008). Hereditary breast and ovarian

cancers. Official Publication of the College of Family Physicians of

Canada, 54(12), 1691–1692.

Carter, R.F. (2001). BRCA1, BRCA2 and breast cancer: A concise

clinical review. Clinical and Investigative Medicine, 24(3), 147–157.

Chapman, D.D. (2007). Cancer genetics. Seminars in Oncology

Nursing, 23(1), 2–9.

Cuningham, K. (2008). Smoking and risk of breast cancer in carriers

of mutations in BRCA1 or BRCA2 aged less than 50 years. Breast

Cancer Research and Treatment, 109, 67–75.

Ensenauer, R.E., Michels, V.V., & Reinke, S.S. (2005). Genetic testing:

practical, ethical, and counseling considerations. Mayo Clinical

Proceedings, 80(1), 63–73.

Evans, J.P., Skrzynia, C., Susswein, L., & Harlan, M. (2005). Genetics and

the young woman with breast cancer. Breast Diseases, 23, 17–29.

Fackenthal, J.D., & Olopade, O.I. (2007). Breast cancer risk associated

with BRCA1 and BRCA2 in diverse populations. Nat Rev Cancer,

(12), 937–48.

Horsman, D., Wilson, B.J., Avard, D., Meschino, W.S., Sing, C.K.,

Plante, M., et al. On behalf of the National Hereditary Cancer Task

Force. (2007). Clinical management recommendations for

surveillance and risk-reduction strategies for hereditary breast

and ovarian cancer among individuals carrying a deleterious

BRCA1 or BRCA2 mutation. Journal of Obstetrics and

Gynaecology Canada, 29(1), 45–60.

Kotsopoulos, J., Lubinski, J., Lynch, H. T., Klijn, J., Ghadirian, P., &

Neuhausen, S.L., et al. The Hereditary Breast Cancer Clinical

Study Group. (2007). Age at first birth and the risk of breast

cancer in BRCA1 and BRCA2 mutation carriers. Breast Cancer

Research and Treatment, 105(2), 221–228.

Loescher, L.J., & Whitesell, L. (2006). The Biology of Cancer. In A.S.

Tranin, A. Masny & J. Jenkins (Eds.), Genetics in oncology practice:

Cancer risk assessment (2nd ed., pp. 23–55). Pittsburgh, PA:

Oncology Nursing Association.

McGuire, V., John, E.M., Felberg, A., Haile, R.W., Boyd, N.F., & Thomas,

D.C., et al. (2006). No increased risk of breast cancer associated

with alcohol consumption among carriers of BRCA1 and BRCA2

mutations ages <50 years. Cancer Epidemiology, Biomakers &

Prevention, 15, 1565–1567.

Mitchell, P.H., Gallucci, B., & Fought, S.G. (1991). Perspectives on human

response to health and illness. Nursing Outlook, 39(4), 154–157.

Narod, S.A., & Foulkes, W.D. (2004). BRCA1 and BRCA2: 1994 and

beyond. Nature Reviews Cancer, September(4), 665–676.

Nkondjock, A., & Ghadirian, P. (2004). Epidemiology of breast cancer

among BRCA mutation carriers: An overview. Cancer Letters, 205,

–8.

Petrucelli, N., Daly, M.B., Culver, J.O., Feldman, G.L. (2007). BRCA1

and BRCA2 hereditary breast/ovarian cancer. Gene Reviews.

Retrieved from http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?

book=gene∂=brca1

Phelps, C., Wood, F., Bennett, P., Brain, K., & Gray, J. (2007).

Knowledge and expectations of women undergoing cancer genetic

risk assessment: A qualitative analysis of free-test questionnaire

comments. Journal of Genetic Counseling, 16(4), 505–514.

Ronckers, C.M., Erdmann, C.A., & Land, C.E. (2005). Radiation and

breast cancer: A review of current evidence. Breast Cancer

Research, 7(1), 21–32.

Rosen, E.M., Fan, S., & Isaacs, C. (2005). Review BRCA1 in hormonal

carcinogenesis; basic and clinical research. Endocrine-Related

Cancer, 12(3), 533–548.

Schlich-Bakker, K.J., ten Kroode, H.F.J., & Ausems, M.G.E.M. (2006). A

literature review of the psychological impact of genetic testing

on breast cancer patients. Patient Education and Counseling,

(1), 13–20.

Schwartz, M.D., Peshkin, B.N., Hughes, C., Main, D., Isaacs, C., &

Lerman. C. (2002). Impact of BRCA1/BRCA2 mutation testing on

psychologic distress in a clinic-based sample. Journal of Clinical

Oncology, 20(2), 514–520.

Sifri, R., Gangadharappa, S., & Acheson, L.S. (2004). Identifying and

testing for hereditary susceptibility to common cancers. A

Cancer Journal for Clinicians, 54, 309–326.

Sivell, S., Iredale, R., Gray, J., & Coles, B. (2007). Cancer genetics risk

assessment for individuals at risk of familial breast cancer (Review).

Cochrane Database of Systematic Reviews, (2), CD003721, 1–30.

Smith, A.W., Dougall, A.L., Posluszny, D.M., Somers, T.J., Rubinstein,

W.S., & Baum, A. (2008). Psychological distress and quality of life

associated with genetic testing for breast cancer risk. Journal of

Psychosocial Oncology, 17, 767–773.

Willey, S.C., & Cocilovo, C. (2007). Screening and follow-up of the

patient at high risk for breast cancer. Obstetrics and Gynecology,

(6), 1404–1416.

Yoshida, K., & Miki, Y. (2004). Role of BRCA1 and BRCA2 as

regulators of DNA repair, transcription and cell cycle in response

to DNA damage. Cancer Science, 95(11), 866–871.


Refbacks

  • There are currently no refbacks.


Bookmark and Share